Global Animal Healthcare Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Animal Healthcare Market was valued at $65.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.4% CAGR, to an estimated market size of $85.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global animal healthcare market comprises the development, manufacturing, and distribution of pharmaceuticals, biologicals (vaccines), medicinal feed additives, and diagnostic tools used for the prevention, management, and treatment of diseases in both companion animals (pets) and livestock (production animals). While the broader ecosystem includes veterinary services and clinical labor, this market scope focuses primarily on the product-based value chain and associated digital health technologies.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Animal Healthcare Market in the period 2025-30:
- The pet humanization trend is driving significant owner investment in advanced therapeutics such as oncology, dermatology, and chronic pain management.
- Rising global demand for animal protein necessitates enhanced livestock health management to ensure food security and supply chain stability.
- The One Health initiative is accelerating government investment in zoonotic disease surveillance and pandemic mitigation strategies.
- A shift toward antimicrobial stewardship is replacing traditional growth-promoting antibiotics with narrow-spectrum drugs, probiotics, and autogenous vaccines.
- Adoption of digital transformation tools, including AI-enabled diagnostics and precision livestock sensors, is improving early disease detection and treatment compliance.
- Increased pet insurance penetration in developed markets is reducing price sensitivity for high-cost diagnostic procedures like MRI and genomic testing.
- Rapid innovation in biotechnology is leading to the commercialization of monoclonal antibodies and recombinant vector vaccines for veterinary use.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Pharmaceuticals
- Biologicals & Vaccines
- Medicinal Feed Additives
- Diagnostics & Digital Health